Pfizer
PFE
2,042 hedge funds and large institutions have $151B invested in Pfizer in 2017 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 823 increasing their positions, 902 reducing their positions, and 68 closing their positions.
18% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 68
16% more call options, than puts
Call options by funds: $1.45B | Put options by funds: $1.25B
8% more funds holding in top 10
Funds holding in top 10: 164 → 177 (+13)
8% more capital invested
Capital invested by funds: $141B → $151B (+$10.6B)
1.16% more ownership
Funds ownership: 73.89% → 75.05% (+1.2%)
0% less funds holding
Funds holding: 2,050 → 2,042 (-8)
9% less repeat investments, than reductions
Existing positions increased: 823 | Existing positions reduced: 902
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$451M |
| 2 |
Two Sigma Advisers
New York
|
+$231M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$217M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$211M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$210M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$249M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$222M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$196M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$156M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$115M |
PFE Hedge Fund Activity: Q3 2017 in Review
2,042 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2017, worth a combined $151B — up 7.6% from $141B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new PFE positions and 68 closed out — a net gain of 12 holders — while 823 added to existing stakes and 902 trimmed.
The largest buyer was Bank of America, adding an estimated $451M. The largest seller was State Street, cutting an estimated $249M.
- 2,042 institutional investors held Pfizer (PFE) as of Q3 2017, down from 2,050 in Q2 2017.
- Funds reported $151B of Pfizer stock for Q3 2017, up 7.6% quarter-over-quarter.
- 80 funds opened new Pfizer positions in Q3 2017 and 68 closed out, a net change of +12 holders.
- The largest Pfizer buyer in Q3 2017 was Bank of America, an estimated $451M added.
- The largest Pfizer seller in Q3 2017 was State Street, an estimated $249M sold.
Based on aggregated 13F filings for Q3 2017.